DABIGATRAN Spirig HC caps 110 mg 60 pce

7680690550011 CH-69055 B01AE07 06.03.0.

Active substances:

DABIGATRAN Spirig HC caps 110 mg 60 pce
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6905501
CPT
-
Packaging group
60
Unit
Kapsel(n)
Composition
dabigatranum etexilatum 110 mg ut dabigatrani etexilati mesilas, acidum tartaricum, acaciae gummi, hydroxypropylcellulosum, hypromellosum, talcum, dimeticonum 350, Kapselhülle: hypromellosum, kalii chloridum, carrageenanum, E 171, E 132, aqua purificata, pro capsula.

Articles (1)

Dabigatran Spirig HC 110 mg, Hartkapseln
Kapseln
60
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/09/2026
Patient information leaflet
Français
01/09/2026
Patient information leaflet
Italien
01/09/2026
Professional SmPC
Allemand
01/09/2026
Professional SmPC
Français
01/09/2026
Professional SmPC
Italien
01/09/2026

Detailed composition

Substance Quantity Type Category
dabigatranum etexilatum
110.0 MG Substance Wirkstoff (Principe actif)
dabigatrani etexilati mesilas
- Substance WIZUS
acidum tartaricum
- Substance HNIDK
acaciae gummi
- Substance HNIDK
hydroxypropylcellulosum
- Substance HNIDK
hypromellosum
- Substance HNIDK
talcum
- Substance HNIDK
dimeticonum 350
- Substance HNIDK
hypromellosum
- Substance HNIDK
kalii chloridum
- Substance HNIDK
carrageenanum
- Substance HNIDK
E 171
- Substance FNIDK
E 132
- Substance FIMDK
aqua purificata
- Substance HNIDK

Reimbursement information

Public price
CHF 60.95
Specialties list
Yes
Generic
Yes
SL addition date: 01/05/2024

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
69055
Drug name
Dabigatran Spirig HC, Hartkapseln
Galenic form
KAHA
ATC Code
B01AE07
Authorization status
Z
Dispensation category
B
First authorization
11/12/2023
Authorization expiration date
10/12/2028
IT number
06.03.0.
Domain
Human medicine
Field of application
Prävention von Schlaganfall und systemischer Embolie bei erwachsenen Patienten mit nicht-valvulärem Vorhofflimmern. Behandlung tiefer Venenthrombosen und/oder Lungenembolien. Prävention der rezidivierenden tiefen Venenthrombose und/oder Lungenembolie.

Packaging details

Description (FR)
DABIGATRAN Spirig HC caps 110 mg 60 pce
Description (DE)
DABIGATRAN Spirig HC Kaps 110 mg 60 Stk
Market launch
11/12/2023
Narcotic (BTM)
No

Original drug

Pradaxa, Kapseln
CHF 65.15
View original

Other packaging sizes

DABIGATRAN Spirig HC caps 110 mg 180 pce
180 KAP
View
DABIGATRAN Spirig HC caps 150 mg 60 pce
60 KAP
View
DABIGATRAN Spirig HC caps 150 mg 180 pce
180 KAP
View
Buy us a coffee Explore the data